Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses

被引:225
作者
Hsue, Priscilla Y.
Hunt, Peter W.
Sinclair, Elizabeth
Bredt, Barry
Franklin, Arlana
Killian, Maudi
Hoh, Rebecca
Martin, Jeffrey N.
McCune, Joseph M.
Waters, David D.
Deeks, Steven G.
机构
[1] Univ Calif San Francisco, Div Cardiol, San Francisco Gen Hosp, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Posit Hlth Program, San Francisco Gen Hosp, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, Gen Clin Res Ctr, San Francisco Gen Hosp, San Francisco, CA 94110 USA
[4] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
cytomegalovirus infection; T-cell responses; carotid arteries; HIV infection;
D O I
10.1097/QAD.0b013e3280108704
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: HIV-infected subjects are at increased risk for myocardial infarction. The mechanism of this increased risk remains unclear. Since cytomegalovirus (CMV) infection has been associated with accelerated atherosclerosis in the transplant population and immune responses against CMV may be altered by HIV disease, we hypothesized that enhanced T-cell responses against CMV would be associated with increased atherosclerosis in subjects with HIV. Methods: We measured high-sensitivity C-reactive protein (hs-CRP), T-cell activation, CMV-specific T-cell responses, and carotid artery intima-media thickness (IMT) in 93 HIV-infected subjects and in 37 uninfected controls. Results: The mean age of the HIV-infected subjects was 48 years and 85 (91%) were male. The median carotid IMT was higher in the HIV-infected group compared to the uninfected group (0.95 mm versus 0.68 mm, P < 0.001). This difference remained significant after controlling for all traditional risk factors. Compared to HIV-negative controls, HIV-infected subjects had higher median levels of hs-CRP (P=0.05), higher levels of CD4 and CD8 T-cell activation (P < 0.0001) and higher CMV-specific interferon-gamma CDS T-cell responses (P < 0.0001). CMV-specific T-cell responses, but not hs-CRP and T-cell activation, were independently associated with higher carotid IMT (P=0.001). Conclusions: HIV-infected subjects had thicker carotid IMT compared to controls. While HIV patients also had higher T-cell activation, hs-CRP levels, and CMV-specific T-cell responses, only CMV-specific T-cell responses were independently associated with IMT. Accelerated atherosclerosis in HIV patients may be mediated by heightened CMV-induced immune responses. (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:2275 / 2283
页数:9
相关论文
共 52 条
[1]   Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele [J].
Alonso-Villaverde, C ;
Coll, B ;
Parra, S ;
Montero, M ;
Calvo, N ;
Tous, M ;
Joven, J ;
Masana, L .
CIRCULATION, 2004, 110 (15) :2204-2209
[2]   Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences [J].
Altfeld, M ;
Addo, MM ;
Shankarappa, R ;
Lee, PK ;
Allen, TM ;
Yu, XG ;
Rathod, A ;
Harlow, J ;
O'Sullivan, K ;
Johnston, MN ;
Goulder, PJR ;
Mullins, JI ;
Rosenberg, ES ;
Brander, C ;
Korber, B ;
Walker, BD .
JOURNAL OF VIROLOGY, 2003, 77 (13) :7330-7340
[3]  
[Anonymous], 13 C RETR OPP INF DE
[4]   Premature ageing of the immune system: the cause of AIDS? [J].
Appay, V ;
Rowland-Jones, SL .
TRENDS IN IMMUNOLOGY, 2002, 23 (12) :580-585
[5]  
Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302
[6]   Carotid intima-media thickness in heavily pretreated HIV-infected patients [J].
Chironi, G ;
Escaut, T ;
Gariepy, J ;
Cogny, A ;
Monsuez, TJ ;
Levenson, J ;
Simon, A ;
Vittecoq, D .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (05) :490-493
[7]   Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure [J].
Currier, JS ;
Kendall, MA ;
Zackin, R ;
Henry, WK ;
Alston-Smith, B ;
Torriani, FJ ;
Schouten, J ;
Mickelberg, K ;
Li, YJ ;
Hodis, HN .
AIDS, 2005, 19 (09) :927-933
[8]   Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1 [J].
Deeks, SG ;
Martin, JN ;
Sinclair, E ;
Harris, J ;
Neilands, TB ;
Maecker, HT ;
Hagos, E ;
Wrin, T ;
Petropoulos, CJ ;
Bredt, B ;
Mccune, JM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (02) :312-321
[9]   Immune activation set point during early FHV infection predicts subsequent CD4+ T-cell changes independent of viral load [J].
Deeks, SG ;
Kitchen, CMR ;
Liu, L ;
Guo, H ;
Gascon, R ;
Narváez, AB ;
Hunt, P ;
Martin, JN ;
Kahn, JO ;
Levy, J ;
McGrath, MS ;
Hecht, FM .
BLOOD, 2004, 104 (04) :942-947
[10]   Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy [J].
Depairon, M ;
Chessex, S ;
Sudre, P ;
Rodondi, N ;
Doser, N ;
Chave, JP ;
Riesen, W ;
Nicod, P ;
Darioli, R ;
Telenti, A ;
Mooser, V .
AIDS, 2001, 15 (03) :329-334